Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP hydrolysis activity	PMS2P1 KIF27 RTEL1 PSMC2 PSMC3 ATAD2 MLH3 ATAD2B KIF19 ABCD2 ATP2A2 ATP2B1	3.54e-06	441	105	12	GO:0016887
GeneOntologyMolecularFunction	ATP-dependent activity	PMS2P1 KIF27 RTEL1 PSMC2 PSMC3 ATAD2 MLH3 ATAD2B KIF19 ABCD2 ATP2A2 ATP2B1	9.25e-05	614	105	12	GO:0140657
Domain	ARM-type_fold	ZYG11A CAND2 ARMC3 IFT172 UBR4 NCDN DIAPH1 ULK4 MMS19 GCN1 HTT SYMPK	4.08e-07	339	104	12	IPR016024
Domain	-	ZYG11A CAND2 ARMC3 ATAD2 ULK4 MMS19 GCN1 HTT SYMPK	4.16e-06	222	104	9	1.25.10.10
Domain	HEAT	CAND2 MMS19 GCN1 HTT SYMPK	6.88e-06	48	104	5	PF02985
Domain	HEAT	CAND2 MMS19 GCN1 HTT SYMPK	1.76e-05	58	104	5	IPR000357
Domain	ATPase_AAA_CS	PSMC2 PSMC3 ATAD2 ATAD2B	1.94e-05	29	104	4	IPR003960
Domain	ARM-like	ZYG11A CAND2 ARMC3 ATAD2 ULK4 MMS19 GCN1 HTT SYMPK	2.00e-05	270	104	9	IPR011989
Domain	Ank_2	ANKRD37 ANKRD10 ANKRD30B ANKRD27 CLIP3 ASB16 DGKI ANKRD33B	2.70e-05	215	104	8	PF12796
Domain	AAA	PSMC2 PSMC3 ATAD2 ATAD2B	3.70e-05	34	104	4	PS00674
Domain	Ank	ANKRD37 ANKRD10 ANKRD30B ANKRD27 CLIP3 ASB16 DGKI ANKRD33B	4.11e-05	228	104	8	PF00023
Domain	HEAT_REPEAT	CAND2 ULK4 MMS19 GCN1 HTT	4.41e-05	70	104	5	PS50077
Domain	-	ANKRD37 ANKRD10 ANKRD30B ANKRD27 CLIP3 ASB16 DGKI ANKRD33B	7.42e-05	248	104	8	1.25.40.20
Domain	ANK	ANKRD37 ANKRD10 ANKRD30B ANKRD27 CLIP3 ASB16 DGKI ANKRD33B	8.07e-05	251	104	8	SM00248
Domain	ANK_REPEAT	ANKRD37 ANKRD10 ANKRD30B ANKRD27 CLIP3 ASB16 DGKI ANKRD33B	8.53e-05	253	104	8	PS50088
Domain	Ankyrin_rpt-contain_dom	ANKRD37 ANKRD10 ANKRD30B ANKRD27 CLIP3 ASB16 DGKI ANKRD33B	8.77e-05	254	104	8	IPR020683
Domain	ANK_REP_REGION	ANKRD37 ANKRD10 ANKRD30B ANKRD27 CLIP3 ASB16 DGKI ANKRD33B	8.77e-05	254	104	8	PS50297
Domain	Talin-1	TLNRD1 TLN1	9.18e-05	3	104	2	IPR015710
Domain	Ankyrin_rpt	ANKRD37 ANKRD10 ANKRD30B ANKRD27 CLIP3 ASB16 DGKI ANKRD33B	1.09e-04	262	104	8	IPR002110
Domain	AAA	PSMC2 PSMC3 ATAD2 ATAD2B	2.00e-04	52	104	4	PF00004
Domain	ATPase_AAA_core	PSMC2 PSMC3 ATAD2 ATAD2B	2.32e-04	54	104	4	IPR003959
Domain	26S_Psome_P45	PSMC2 PSMC3	4.54e-04	6	104	2	IPR005937
Domain	BROMODOMAIN_1	ATAD2 ATAD2B PHIP	1.14e-03	37	104	3	PS00633
Domain	Bromodomain	ATAD2 ATAD2B PHIP	1.23e-03	38	104	3	PF00439
Domain	AAA	PSMC2 PSMC3 ATAD2 ATAD2B ABCD2	1.27e-03	144	104	5	SM00382
Domain	AAA+_ATPase	PSMC2 PSMC3 ATAD2 ATAD2B ABCD2	1.27e-03	144	104	5	IPR003593
Domain	DAGK_acc	DGKG DGKI	1.34e-03	10	104	2	PF00609
Domain	Diacylglycerol_kin_accessory	DGKG DGKI	1.34e-03	10	104	2	IPR000756
Domain	DAGKa	DGKG DGKI	1.34e-03	10	104	2	SM00045
Domain	BROMODOMAIN_2	ATAD2 ATAD2B PHIP	1.53e-03	41	104	3	PS50014
Domain	Bromodomain	ATAD2 ATAD2B PHIP	1.64e-03	42	104	3	IPR001487
Domain	BROMO	ATAD2 ATAD2B PHIP	1.64e-03	42	104	3	SM00297
Domain	-	ATAD2 ATAD2B PHIP	1.64e-03	42	104	3	1.20.920.10
Domain	DAGKc	DGKG DGKI	2.68e-03	14	104	2	SM00046
Domain	Diacylglycerol_kinase_cat_dom	DGKG DGKI	3.08e-03	15	104	2	IPR001206
Domain	DAGK	DGKG DGKI	3.08e-03	15	104	2	PS50146
Domain	DAGK_cat	DGKG DGKI	3.08e-03	15	104	2	PF00781
Domain	ATPase_P-typ_TM_dom	ATP2A2 ATP2B1	3.50e-03	16	104	2	IPR023298
Domain	-	ATP2A2 ATP2B1	3.50e-03	16	104	2	1.20.1110.10
Domain	C1_1	RASGRP4 DGKG DGKI	3.95e-03	57	104	3	PF00130
Domain	ATPase_P-typ_cation-transptr_C	ATP2A2 ATP2B1	3.95e-03	17	104	2	IPR006068
Domain	Cation_ATPase_C	ATP2A2 ATP2B1	3.95e-03	17	104	2	PF00689
Domain	NAD/diacylglycerol_kinase	DGKG DGKI	3.95e-03	17	104	2	IPR016064
Domain	PP2C	TAB1 PPM1N	3.95e-03	17	104	2	IPR015655
Domain	Cation_ATPase_N	ATP2A2 ATP2B1	4.43e-03	18	104	2	PF00690
Domain	Cation_ATPase_N	ATP2A2 ATP2B1	4.43e-03	18	104	2	SM00831
Domain	PP2C	TAB1 PPM1N	4.94e-03	19	104	2	PF00481
Domain	ATPase_P-typ_cation-transptr_N	ATP2A2 ATP2B1	4.94e-03	19	104	2	IPR004014
Domain	ZF_DAG_PE_1	RASGRP4 DGKG DGKI	5.46e-03	64	104	3	PS00479
Domain	ZF_DAG_PE_2	RASGRP4 DGKG DGKI	5.46e-03	64	104	3	PS50081
Domain	PP2Cc	TAB1 PPM1N	5.47e-03	20	104	2	SM00332
Domain	-	TAB1 PPM1N	5.47e-03	20	104	2	3.60.40.10
Domain	PPM-type_phosphatase_dom	TAB1 PPM1N	5.47e-03	20	104	2	IPR001932
Domain	PPM_2	TAB1 PPM1N	5.47e-03	20	104	2	PS51746
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	PRPF31 PLEKHG4 UBR4 RPP30 PSMC2 PSMC3 SHMT2 MCCC1 DCK ATAD2 ANKRD27 WDR59 NUP205 CS SUGP2 CTR9 TLN1 H1-5 DIAPH1 MMS19 ATP2A2 GCN1 MVP ATP2B1 PHIP PCK2	3.45e-14	1353	106	26	29467282
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	CUL4B UBR4 PSMC2 PSMC3 ATAD2 NUP205 SUGP2 TLN1 ATAD2B ATP2A2 GCN1 MVP PHIP SYMPK	1.27e-08	653	106	14	22586326
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	CUL4B IFT172 UBR4 PSMC2 PSMC3 NUP205 SUGP2 CTR9 TLN1 DIAPH1 ATP2A2 GCN1 SYMPK	7.89e-08	638	106	13	33239621
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	CAND2 ADAM15 UBR4 PSMC2 PSMC3 PLXNB2 NCDN NUP205 TLN1 MMS19 ATP2A2 GCN1 TBL2 PCK2 SYMPK	1.81e-07	942	106	15	31073040
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	CAND2 SYNE1 UBR4 PSMC2 PSMC3 SHMT2 PLXNB2 NUP205 CS ATP2A2 GCN1 ATP2B1	1.93e-07	573	106	12	28330616
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	CUL4B UBR4 RPP30 PSMC2 PSMC3 SHMT2 DCK NCDN NUP205 CS CTR9 TLN1 H1-5 DIAPH1 MMS19 GCN1 MVP HTT	4.06e-07	1455	106	18	22863883
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	PRPF31 UBR4 PSMC2 PSMC3 SHMT2 MCCC1 DCK ANKRD27 NUP205 CS CTR9 H1-5 DIAPH1 ATP2A2 GCN1 PHIP PCK2	5.00e-07	1318	106	17	30463901
Pubmed	Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.	OMA1 PRPF31 PSMC3 CTR9 TLN1 ATP2A2 GCN1 MVP ATP2B1 PCK2	7.03e-07	422	106	10	27342126
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	CAND2 IFT172 DUSP1 UBR4 PSMC2 PSMC3 SHMT2 NUP205 CTR9 H1-5 TAB1 GCN1 ATP2B1 TBL2	1.61e-06	974	106	14	28675297
Pubmed	SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response.	SYNE1 PSMC2 PSMC3 SHMT2 NUP205 CS CTR9 ATP2A2 GCN1 ATP2B1	1.62e-06	463	106	10	34901782
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	PRPF31 PDGFRA RPP30 PSMC2 PSMC3 SHMT2 MCCC1 ATAD2 NUP205 SUGP2 CTR9 ATP2A2 CBX2 SYMPK	1.93e-06	989	106	14	36424410
Pubmed	POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.	PRPF31 KIF27 RPP30 PSMC2 PSMC3 H1-5 TAB1 MVP	2.25e-06	277	106	8	30745168
Pubmed	Interactome of the Autoimmune Risk Protein ANKRD55.	PSMC3 NUP205 CS TLN1 MMS19 ATP2A2 GCN1	2.55e-06	197	106	7	31620119
Pubmed	Defining the membrane proteome of NK cells.	PDGFRA ACOX1 UBR4 PSMC2 PSMC3 APOE RETSAT ANKRD27 NCDN NUP205 SERPINB9 MMS19 GCN1 MVP ATP2B1	2.65e-06	1168	106	15	19946888
Pubmed	Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis.	CUL4B PSMC2 PSMC3 SHMT2 TLN1 ATP2A2	5.51e-06	144	106	6	35681168
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	CUL4B SYNE1 PSMC2 PSMC3 SHMT2 DGKG CS TLN1 H1-5 ATP2A2 GCN1 MVP	6.40e-06	803	106	12	36517590
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	PRPF31 KIF27 SYNE1 UBR4 PSMC3 SHMT2 ATAD2 NUP205 CS CTR9 TLN1 DIAPH1 ATP2A2 GCN1 ATP2B1 PHIP	6.61e-06	1425	106	16	30948266
Pubmed	Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations.	CUL4B KIF27 UBR4 TLN1 DIAPH1 GCN1 PCK2	8.12e-06	235	106	7	28378594
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	CUL4B PSMC2 SHMT2 MCCC1 NCDN CTR9 DIAPH1 MMS19 TBL2 SYMPK	8.64e-06	560	106	10	35241646
Pubmed	Targeted ubiquitination and degradation of G-protein-coupled receptor kinase 5 by the DDB1-CUL4 ubiquitin ligase complex.	CUL4B CAND2 PSMC2 MMS19 TAB1 TBL2	8.72e-06	156	106	6	22952844
Pubmed	Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.	BCHE APOE	9.20e-06	2	106	2	18334913
Pubmed	Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.	BCHE APOE	9.20e-06	2	106	2	27567841
Pubmed	Influence of genetic polymorphisms in the apolipoprotein (APOE) and the butyrylcholinesterase (BCHE) gene on stress markers in older adults: a 3-year study.	BCHE APOE	9.20e-06	2	106	2	17996334
Pubmed	Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.	BCHE APOE	9.20e-06	2	106	2	30914707
Pubmed	Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism.	BCHE APOE	9.20e-06	2	106	2	16973370
Pubmed	Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.	BCHE APOE	9.20e-06	2	106	2	26757188
Pubmed	Identification of Neurochondrin as a new interaction partner of the FH3 domain of the Diaphanous-related formin Dia1.	NCDN DIAPH1	9.20e-06	2	106	2	18572016
Pubmed	Lack of mitogen-activated protein kinase phosphatase-1 protects ApoE-null mice against atherosclerosis.	DUSP1 APOE	9.20e-06	2	106	2	20093631
Pubmed	The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women.	BCHE APOE	9.20e-06	2	106	2	11125748
Pubmed	Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo.	BCHE APOE	9.20e-06	2	106	2	20538374
Pubmed	Age-dependent association between butyrylcholinesterase K-variant and Alzheimer disease-related neuropathology in human brains.	BCHE APOE	9.20e-06	2	106	2	11849755
Pubmed	The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase.	BCHE APOE	9.20e-06	2	106	2	19713000
Pubmed	Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups.	BCHE APOE	9.20e-06	2	106	2	11738493
Pubmed	Collaborative effect of SERCA and PMCA in cytosolic calcium homeostasis in human platelets.	ATP2A2 ATP2B1	9.20e-06	2	106	2	16669348
Pubmed	Bmper inhibits endothelial expression of inflammatory adhesion molecules and protects against atherosclerosis.	APOE BMPER	9.20e-06	2	106	2	22772758
Pubmed	BuChE K variant is decreased in Alzheimer's disease not in fronto-temporal dementia.	BCHE APOE	9.20e-06	2	106	2	20058037
Pubmed	Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.	BCHE APOE	9.20e-06	2	106	2	32250307
Pubmed	Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.	BCHE APOE	9.20e-06	2	106	2	29254094
Pubmed	BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline.	BCHE APOE	9.20e-06	2	106	2	19006190
Pubmed	A TCF7L2-responsive suppression of both homeostatic and compensatory remyelination in Huntington disease mice.	PDGFRA HTT	9.20e-06	2	106	2	36044851
Pubmed	Butyrylcholinesterase K variant and the APOE-epsilon 4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients.	BCHE APOE	9.20e-06	2	106	2	19685167
Pubmed	No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.	BCHE APOE	9.20e-06	2	106	2	19481150
Pubmed	Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease.	BCHE APOE	9.20e-06	2	106	2	24479631
Pubmed	Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers.	BCHE APOE	9.20e-06	2	106	2	38594621
Pubmed	Divergent JAM-C Expression Accelerates Monocyte-Derived Cell Exit from Atherosclerotic Plaques.	APOE JAM3	9.20e-06	2	106	2	27442505
Pubmed	Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.	BCHE APOE	9.20e-06	2	106	2	15519745
Pubmed	Effect of apolipoprotein E and butyrylcholinesterase genotypes on cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease.	BCHE APOE	9.20e-06	2	106	2	20644562
Pubmed	A disintegrin and metalloproteinase 15 contributes to atherosclerosis by mediating endothelial barrier dysfunction via Src family kinase activity.	ADAM15 APOE	9.20e-06	2	106	2	22904271
Pubmed	Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome.	RTEL1 TERF1	9.20e-06	2	106	2	23959892
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	PRPF31 CAND2 UBR4 RPP30 PSMC2 PSMC3 SHMT2 NUP205 SUGP2 GCN1 PCK2	1.05e-05	704	106	11	29955894
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	CUL4B SYNE1 ACOX1 UBR4 CS SERPINB9 TLN1 MYPN MMS19 TAB1 GCN1 MVP	1.05e-05	844	106	12	25963833
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	UBR4 PSMC2 PSMC3 APOE RETSAT NUP205 TLN1 DIAPH1 ATP2A2 GCN1 PCK2	1.16e-05	711	106	11	33022573
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	PRPF31 SYNE1 SHMT2 PLXNB2 NCDN NUP205 CS SUGP2 TLN1 ATP2A2 GCN1 ATP2B1 PHIP	1.47e-05	1024	106	13	24711643
Pubmed	Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation.	PSMC2 PSMC3 ATAD2 NUP205 MMS19 ATP2A2 GCN1	1.94e-05	269	106	7	30442662
Pubmed	TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation.	PDGFRA PSMC3 ATP2A2 PHIP CBX2	2.17e-05	109	106	5	33554859
Pubmed	Interactome mapping suggests new mechanistic details underlying Alzheimer's disease.	EGLN2 TCN2 RPP30 APOE NCDN	2.37e-05	111	106	5	21163940
Pubmed	Autoregulation of the 26S proteasome by in situ ubiquitination.	UBR4 PSMC2 PSMC3	2.57e-05	19	106	3	24743594
Pubmed	Dioxin receptor is a ligand-dependent E3 ubiquitin ligase.	CUL4B PSMC2 PSMC3	2.57e-05	19	106	3	17392787
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	UBR4 RPP30 SUGP2 CTR9 MMS19 GCN1 CBX2	2.63e-05	282	106	7	23667531
Pubmed	Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models.	DUSP1 APOE	2.76e-05	3	106	2	15242861
Pubmed	Central region of talin has a unique fold that binds vinculin and actin.	TLNRD1 TLN1	2.76e-05	3	106	2	20610383
Pubmed	Cutting edge: JAM-C controls homeostatic chemokine secretion in lymph node fibroblastic reticular cells expressing thrombomodulin.	PDGFRA JAM3	2.76e-05	3	106	2	21685324
Pubmed	Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis.	PDGFRA SHMT2	2.76e-05	3	106	2	30367038
Pubmed	Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects.	BCHE APOE	2.76e-05	3	106	2	11793025
Pubmed	Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease.	BCHE APOE	2.76e-05	3	106	2	12074828
Pubmed	Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels.	DUSP1 APOE	2.76e-05	3	106	2	20619710
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	CAND2 UBR4 PSMC2 PSMC3 SHMT2 MCCC1 NUP205 TLN1 H1-5 MMS19 ATP2A2 GCN1 ATP2B1 TBL2 PCK2	3.16e-05	1440	106	15	30833792
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	UBR4 RPP30 PSMC2 PSMC3 TLN1 MMS19 GCN1 ATP2B1	3.17e-05	399	106	8	37536630
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ANKRD37 UBR4 PLXNB2 WDR59 TLNRD1 SUGP2 TLN1 ULK4 GCN1 ANKRD33B HTT CBX2 SYMPK	3.24e-05	1105	106	13	35748872
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	SYNE1 UBR4 PSMC3 SHMT2 MCCC1 CS TLN1 H1-5 DIAPH1 ATP2A2 GCN1	3.69e-05	807	106	11	30575818
Pubmed	Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach.	RPP30 PSMC2 PSMC3 MMS19 ATP2A2 GCN1	4.78e-05	211	106	6	17314511
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	PRPF31 CAND2 UBR4 PSMC2 PSMC3 SHMT2 TLN1 DIAPH1 MMS19 TAB1 ATP2A2 GCN1 SYMPK	4.84e-05	1149	106	13	35446349
Pubmed	mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.	PSMC2 NUP205 TLN1 H1-5 GCN1 MVP ATP2B1	4.99e-05	312	106	7	37120454
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	CUL4B UBR4 PSMC2 PSMC3 SHMT2 DGKI MMS19 PCK2 CBX2 SYMPK	5.04e-05	689	106	10	36543142
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	RASGRP4 PDGFRA WNT10B UBR4 SHMT2 MAU2 ATAD2 WDR59 NUP205 TLNRD1 CS CTR9 GCN1 HTT	5.17e-05	1327	106	14	32694731
Pubmed	A Requirement for Zic2 in the Regulation of Nodal Expression Underlies the Establishment of Left-Sided Identity.	FEZF1 FZD5 FOXD4	5.32e-05	24	106	3	29992973
Pubmed	Herpesvirus deconjugases inhibit the IFN response by promoting TRIM25 autoubiquitination and functional inactivation of the RIG-I signalosome.	PSMC2 PSMC3 NUP205 ATP2B1	5.39e-05	67	106	4	29357390
Pubmed	Model Predicts That MKP1 and TAB1 Regulate p38α Nuclear Pulse and Its Basal Activity through Positive and Negative Feedback Loops in Response to IL-1.	DUSP1 TAB1	5.50e-05	4	106	2	27314954
Pubmed	Exome Sequencing Identifies Genes and Gene Sets Contributing to Severe Childhood Obesity, Linking PHIP Variants to Repressed POMC Transcription.	DGKI PHIP	5.50e-05	4	106	2	32492392
Pubmed	Improved prediction of early-onset coronary artery disease using APOE epsilon4, BChE-K, PPARgamma2 Pro12 and ENOS T-786C in a polygenic model.	BCHE APOE	5.50e-05	4	106	2	16298355
Pubmed	Peptide sequencing identifies MSS1, a modulator of HIV Tat-mediated transactivation, as subunit 7 of the 26 S protease.	PSMC2 PSMC3	5.50e-05	4	106	2	8500623
Pubmed	Association of the 19S proteasomal ATPases with the ATPase-binding domain of CIITA is essential for CIITA stability and MHC class II expression.	PSMC2 PSMC3	5.50e-05	4	106	2	20351748
Pubmed	Expression of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal mouse cardiovascular tissues, heart failure and atherosclerosis.	APOE ATP2A2	5.50e-05	4	106	2	25110346
Pubmed	Alzheimer's disease: case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample.	BCHE APOE	5.50e-05	4	106	2	17503475
Pubmed	Common variations in 4p locus are related to male completed suicide.	EVC HTT	5.50e-05	4	106	2	19115052
Pubmed	The nongastric H+-K+-ATPases: molecular and functional properties.	ATP2A2 ATP2B1	5.50e-05	4	106	2	10362770
Pubmed	Major vault protein suppresses obesity and atherosclerosis through inhibiting IKK-NF-κB signaling mediated inflammation.	APOE MVP	5.50e-05	4	106	2	30996248
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	CUL4B PRPF31 UBR4 MAU2 NUP205 BROX SUGP2 CTR9 H1-5 DIAPH1 MMS19 SYMPK	6.29e-05	1014	106	12	32416067
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	UBR4 PSMC3 CTR9 TLN1 MMS19 GCN1 SYMPK	7.36e-05	332	106	7	32786267
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	RPP30 PSMC3 MAU2 TERF1 ATRIP ATP2A2 ATP2B1 CBX2	7.71e-05	453	106	8	29656893
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	CUL4B PSMC2 SHMT2 TLN1 H1-5 MMS19 ATP2A2 GCN1 ATP2B1 PCK2 HTT	7.84e-05	878	106	11	37223481
Pubmed	Functional proteomics mapping of a human signaling pathway.	EGLN2 RARB UBR4 PSMC2 TERF1 ANKRD27 CTR9 POLI DIAPH1	8.46e-05	591	106	9	15231748
Pubmed	Differential left-to-right atria gene expression ratio in human sinus rhythm and atrial fibrillation: Implications for arrhythmogenesis and thrombogenesis.	APOE ATP2A2	9.15e-05	5	106	2	27494721
Pubmed	ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.	APOE BMPER	9.15e-05	5	106	2	24770881
Pubmed	Genetic susceptibility to accelerated cognitive decline in the US Health and Retirement Study.	APOE DGKI	9.15e-05	5	106	2	24468470
Pubmed	Molecular double clips within RepID WD40 domain control chromatin binding and CRL4-substrate assembly.	CUL4B PHIP	9.15e-05	5	106	2	34171797
Pubmed	RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes.	PSMC3 MCCC1 NUP205 H1-5 DIAPH1 ATP2A2 GCN1	9.19e-05	344	106	7	36282215
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	CAND2 DUSP1 UBR4 RPP30 PSMC2 PSMC3 SHMT2 NUP205 CTR9 MMS19 ATP2A2 GCN1 TBL2	1.19e-04	1257	106	13	37317656
Pubmed	Susceptibility groups for Alzheimer's disease (OPTIMA cohort): integration of gene variants and biochemical factors.	BCHE APOE	1.37e-04	6	106	2	17116317
Pubmed	ASK1 negatively regulates the 26 S proteasome.	PSMC2 PSMC3	1.37e-04	6	106	2	20843792
Interaction	TPTE interactions	CAND2 UBR4 NUP205 TLN1 ATP2A2 GCN1 ATP2B1 TBL2	3.00e-07	129	102	8	int:TPTE
Interaction	NPTN interactions	CAND2 PLEKHG4 APOE MMS19 ATP2A2 GCN1 ATP2B1 CNTN1 HTT SYMPK	1.48e-06	278	102	10	int:NPTN
Interaction	UNC93B1 interactions	CAND2 UBR4 PSMC2 PSMC3 MCCC1 NUP205 MMS19 ATP2A2 GCN1 ATP2B1 TBL2	8.59e-06	417	102	11	int:UNC93B1
Interaction	PSMD14 interactions	PRPF31 KIF27 UBR4 RPP30 PSMC2 PSMC3 NLRP9 CS H1-5 TAB1 MVP HTT	1.44e-05	527	102	12	int:PSMD14
Interaction	SIRT7 interactions	CUL4B UBR4 PSMC2 PSMC3 ATAD2 NUP205 SUGP2 TLN1 ATAD2B ATP2A2 GCN1 MVP PHIP SYMPK	2.27e-05	744	102	14	int:SIRT7
Interaction	P2RY6 interactions	CAND2 UBR4 PSMC2 PSMC3 H1-5 ATP2A2 GCN1 ATP2B1 TBL2 PCK2	2.58e-05	385	102	10	int:P2RY6
Interaction	ATP1A1 interactions	CUL4B OMA1 PSMC2 PSMC3 SHMT2 NCDN TLN1 MMS19 MAPK4 ATP2A2 ATP2B1 HTT	3.39e-05	575	102	12	int:ATP1A1
Interaction	PMS2 interactions	PMS2P1 PSMC2 PSMC3 CTR9 MMS19	5.35e-05	80	102	5	int:PMS2
Interaction	DUSP2 interactions	UBR4 NUP205 MAPK4 GCN1 ATP2B1	5.68e-05	81	102	5	int:DUSP2
Interaction	NR2C2 interactions	CUL4B PRPF31 UBR4 PSMC2 PSMC3 SHMT2 MCCC1 DCK ANKRD27 NUP205 CS CTR9 H1-5 DIAPH1 TAB1 ATP2A2 GCN1 PHIP PCK2	7.02e-05	1403	102	19	int:NR2C2
Interaction	MAPK12 interactions	DUSP1 SHMT2 TERF1 TAB1 GCN1	7.57e-05	86	102	5	int:MAPK12
Interaction	LMBR1L interactions	CAND2 ADAM15 UBR4 PSMC2 PSMC3 PLXNB2 NCDN NUP205 TLN1 MMS19 ATP2A2 GCN1 TBL2 PCK2 SYMPK	8.08e-05	946	102	15	int:LMBR1L
GeneFamily	Ankyrin repeat domain containing	ANKRD37 ANKRD10 ANKRD30B ANKRD27 CLIP3 ASB16 DGKI ANKRD33B	2.70e-06	242	66	8	403
GeneFamily	AAA ATPases	PSMC2 PSMC3 ATAD2 ATAD2B	4.15e-05	53	66	4	413
GeneFamily	ATPases Ca2+ transporting	ATP2A2 ATP2B1	4.65e-04	9	66	2	1209
GeneFamily	EF-hand domain containing\|Diacylglycerol kinases	DGKG DGKI	5.80e-04	10	66	2	1178
GeneFamily	WD repeat domain containing	IFT172 WDR54 WDR59 PHIP TBL2	2.68e-03	262	66	5	362
ToppCell	343B-Lymphocytic-ILC-ILC-1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ANKRD37 NUP205 FGFBP3 KIF19 TAB1 HTT	7.06e-06	192	107	6	445985fe1bcd33e4f0a1704b27988fbfc9334538
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TCN2 SHMT2 PKD2L1 KIF19 DGKI JAM3	7.49e-06	194	107	6	2dcc3b99dbedaf8a6916891c85091ddb79d7ee31
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PDGFRA SYNE1 DGKG CLIP3 KIF19 CNTN1	8.66e-06	199	107	6	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PDGFRA SYNE1 DGKG CLIP3 KIF19 CNTN1	8.66e-06	199	107	6	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PDGFRA SYNE1 DGKG CLIP3 KIF19 CNTN1	8.66e-06	199	107	6	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
Drug	HMDS	TCN2 IFT172 SYNE1 DCK	2.50e-06	21	106	4	CID000013838
Disease	Colorectal Carcinoma	OMA1 RARB TCN2 SYNE1 JAKMIP2 NCDN MLH3 H1-5 ABCD2 PHIP CNTN1	2.92e-05	702	101	11	C0009402
Disease	parental longevity	RARB PKD2L1 APOE PLXNB2 ANKRD27 CCDC171 ANKRD33B PHIP HTT	5.14e-05	494	101	9	EFO_0007796
Disease	cold shock domain-containing protein C2 measurement	BCHE APOE	6.93e-05	4	101	2	EFO_0802415
Disease	RING finger protein 122 measurement	BCHE APOE	6.93e-05	4	101	2	EFO_0803028
Disease	transcobalamin-2 measurement	TCN2 SLC35E4	6.93e-05	4	101	2	EFO_0802139
Disease	fatty acid measurement, linoleic acid measurement	KIF27 MAU2 APOE CCDC171	8.90e-05	68	101	4	EFO_0005110, EFO_0006807
Disease	low-density lipoprotein receptor measurement	BCHE APOE	1.15e-04	5	101	2	EFO_0021937
Disease	palmitoleoyl-linoleoyl-glycerol (16:1/18:2) [1] measurement	PKD2L1 MAU2	1.15e-04	5	101	2	EFO_0800504
Disease	dermokine measurement	BCHE APOE	1.72e-04	6	101	2	EFO_0802462
Disease	carbohydrate intake measurement	RARB APOE CCDC171	2.16e-04	34	101	3	EFO_0010811
Disease	small nuclear ribonucleoprotein F measurement	BCHE APOE	4.11e-04	9	101	2	EFO_0008288
Disease	epididymal-specific lipocalin-10 measurement	BCHE APOE	4.11e-04	9	101	2	EFO_0801576
Disease	stromal interaction molecule 1 measurement	BCHE APOE	5.13e-04	10	101	2	EFO_0802093
Disease	f-box/LRR-repeat protein 4 measurement	BCHE APOE	5.13e-04	10	101	2	EFO_0802538
Disease	cytochrome p450 3a4 measurement	BCHE APOE	6.25e-04	11	101	2	EFO_0020303
Disease	cup-to-disc ratio measurement	RARB PDGFRA ADAM15 DUSP1 MYPN CCDC171 SYMPK	7.05e-04	430	101	7	EFO_0006939
Disease	protein CEI measurement	BCHE APOE	7.49e-04	12	101	2	EFO_0801936
Disease	tumor protein p53-inducible protein 11 measurement	BCHE APOE	7.49e-04	12	101	2	EFO_0802169
Disease	integral membrane protein 2B measurement	BCHE APOE	7.49e-04	12	101	2	EFO_0802634
Disease	inactive gamma-glutamyltranspeptidase 2 measurement	BCHE APOE	7.49e-04	12	101	2	EFO_0801692
Disease	RAC-beta serine/threonine-protein kinase measurement	BCHE APOE	8.83e-04	13	101	2	EFO_0021989
Disease	tRNA (guanine-N(7)-)-methyltransferase measurement	BCHE APOE	8.83e-04	13	101	2	EFO_0802162
Disease	eosinophil percentage of leukocytes	RASGRP4 RARB KIF27 ADAM15 NUP205 POLI ANKRD33B MAST3 SYMPK	1.06e-03	746	101	9	EFO_0007991
Disease	sleep measurement	KIF27 PSMC3 JAKMIP2 CTR9	1.21e-03	135	101	4	EFO_0004870
Disease	ceramide measurement	PKD2L1 MAU2 APOE SLC35E4 CCDC171	1.31e-03	235	101	5	EFO_0010222
Disease	liver fat measurement, liver disease biomarker	APOE PCK2	1.35e-03	16	101	2	EFO_0006845, EFO_0010821
Disease	Abdominal Aortic Aneurysm	OMA1 OR1J1 APOE	1.66e-03	68	101	3	EFO_0004214
Disease	androstenedione measurement, estrone measurement	ARMC3 BMPER	1.71e-03	18	101	2	EFO_0007970, EFO_0007972
Disease	gait measurement	RARB ADAM15 MAST3 HTT	1.79e-03	150	101	4	EFO_0007680
Disease	hydrocephalus (implicated_via_orthology)	KIF27 ULK4	1.91e-03	19	101	2	DOID:10908 (implicated_via_orthology)
Disease	sodium-coupled monocarboxylate transporter 1 measurement	BCHE APOE	1.91e-03	19	101	2	EFO_0802076
Disease	age at first sexual intercourse measurement	OMA1 RARB ARMC3 TERF1 NUP205 FEZF1	2.07e-03	383	101	6	EFO_0009749
Disease	asthma, endometriosis	RARB PLXNB2 SYMPK	2.12e-03	74	101	3	EFO_0001065, MONDO_0004979
Disease	HbA1c measurement	ADAM15 HKDC1 PKD2L1 APOE ATRIP ASB16 ATAD2B MYPN	2.25e-03	675	101	8	EFO_0004541
Disease	saturated fatty acids to total fatty acids percentage	PKD2L1 APOE	2.33e-03	21	101	2	EFO_0022305
Disease	complex trait	IFT172 MAU2 APOE SUGP2 TBL2	2.44e-03	271	101	5	EFO_0010578
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	PKD2L1 MAU2 APOE	2.46e-03	78	101	3	EFO_0022187
Disease	serum alanine aminotransferase measurement	HKDC1 PKD2L1 MAU2 APOE PLXNB2 DIAPH1 TBL2 MAST3 HTT	2.99e-03	869	101	9	EFO_0004735
Disease	total brain volume change measurement, age at assessment	APOE MAPK4	3.31e-03	25	101	2	EFO_0008007, EFO_0021504

Protein segments in the cluster

Peptide	Gene	Start	Entry
LTAREACAKGLVSQV	CDY1	451	Q9Y6F8
EARNRTLNLAKLTGC	BCHE	266	P06276
AALLVTFLAGCQAKV	APOE	6	P02649
AARLVEGTSAKIQCL	ANKRD30B	306	Q9BXX2
KAARSGSLECISALV	ANKRD10	131	Q9NXR5
RSSAAKRAACLVAAA	ABCD2	16	Q9UBJ2
SNCSRRALEKALLDG	ADAM15	391	Q13444
ANRLKILGQSCASLF	CCDC171	811	Q6TFL3
CAKLLLEAGATVNLA	ASB16	191	Q96NS5
TGKTLVARALANECS	ATAD2	471	Q6PL18
LLSSKRDGAIANAAT	ARMC3	406	Q5W041
ANRKAGCAVTSLLAS	DIAPH1	1221	O60610
NINTARAIATKCGIL	ATP2B1	711	P20020
TATLLRAACANNVGL	ANKRD33B	86	A6NCL7
AAKVGSLECLSLLVA	ANKRD37	71	Q7Z713
GLTIADQITLLKAAC	RARB	251	P10826
SRAALEALGSCLNNK	SHMT2	81	P34897
CIANSLKALIQSRRG	NUP205	141	Q92621
AVCGQASLIDLLVSK	ANKRD27	471	Q96NW4
TIAVRCLAKNLLGAE	PDGFRA	496	P16234
CLLAAARREKGAASN	FGFBP3	21	Q8TAT2
IQRLKSALCALRDGS	JAKMIP2	111	Q96AA8
KCLVLASLVALLGSA	JSRP1	126	Q96MG2
ALKLAARLAHACGSD	NCDN	281	Q9UBB6
NGLVLSAVDSRACRK	MAPK4	31	P31152
SAKLLQAAAGASARA	MMS19	371	Q96T76
GKTLVARALANECSQ	ATAD2B	446	Q9ULI0
SRGEANVLEKLACLS	KIF27	1091	Q86VH2
NSLLGKKCFALRIAS	PCK2	256	Q16822
FKGICALRALSNISL	PLXNB2	116	O15031
AKLRSGLAISSLGQC	MLH3	11	Q9UHC1
ALGCRIAELCASAQK	PPM1N	346	Q8N819
LRASAICSKLGLAFL	RASGRP4	526	Q8TDF6
RLNSAEAAAKALSTC	OR56B1	236	Q8NGI3
LGFLASTCADKRTIA	GCN1	1931	Q92616
GCLIGAVNLKSSNRT	JAM3	26	Q9BX67
LTLLLAFGKNAVRCA	PMS2P1	116	A4D2B8
LRKLLSRSGAVAHAC	OR1J1	301	Q8NGS3
ADASLSALRVSCKGS	FOXD4	316	Q12950
GNAALNSKLCDLLLS	ALAS2	481	P22557
ACKAIASRVRGAVAS	MVP	571	Q14764
RCSIKAIEAALGARQ	IFT172	881	Q9UG01
SLLALGNCINALSDK	KIF19	276	Q2TAC6
AGSVLSCKNAQLARD	FAM189B	111	P81408
TGLKSAGRRLAQCAS	DGKG	721	P49619
LLAQLVGRAAAASKA	FZD5	16	Q13467
VGEAARALSKACTIA	ACOX1	286	Q15067
GLSKIERANACNSVI	ATP2A2	461	P16615
VKALALSCVGAAVAL	HTT	711	P42858
VAASKERNGLSLAAL	H1-5	51	P16401
VLSRDCALAIKQRGA	BMPER	86	Q8N8U9
ASRLALKAQATNKCG	CBX2	271	Q14781
AKRDGTLALAAGALC	DUSP1	96	P28562
CQLLVDAGASLRKTD	DGKI	1011	O75912
AAARLLGTKNASCLV	CS	6	O75390
LGTKNASCLVLAARH	CS	11	O75390
SLEGKVSLNCRARAS	CNTN1	56	Q12860
FSRALELNSKCVGAL	CTR9	221	Q6PD62
KAAAKESLCQAALGL	MCCC1	501	Q96RQ3
LARDCLAKSGENLVT	MAST3	221	O60307
CLSRIRAQLASLNGK	DCK	101	P27707
AACKSDARLLLGRDA	EVC	6	P57679
AAALVTKGCQRLAAQ	EGLN2	96	Q96KS0
CQALQDLAAAKRSGA	ATRIP	431	Q8WXE1
ALHIAASSLCLGAAK	CLIP3	201	Q96DZ5
LKARSCSAARLASAQ	C1orf174	16	Q8IYL3
VRRAAAKCIAALISS	CAND2	351	O75155
CAGVASNKLLAKLVS	POLI	221	Q9UNA4
SSALLRDLNKACGNA	MAU2	541	Q9Y6X3
TLQSLACGKARVLAK	CUL4B	781	Q13620
DAKAAVSTNCRAALL	RPP30	216	P78346
ALQGALLCSSAILKR	RETSAT	576	Q6NUM9
ECLSSLGKALGNIAR	RTEL1	536	Q9NZ71
GKTLCARAVANRTDA	PSMC2	221	P35998
DKLLVSLGASRFCLQ	TAS2R60	56	P59551
KAIQDRLACAESTLG	SYNE1	2641	Q8NF91
ANVGTNRALLCKSTV	TAB1	181	Q15750
RSANLCAAALAAILT	HKDC1	381	Q2TB90
AACALLQGAIESVKA	PLEKHG4	346	Q58EX7
LNCALSLKGDLARDA	FEZF1	121	A0PJY2
QLLLCASLAAAAAGL	OCSTAMP	51	Q9BR26
LLAAKACADIRASSV	OMA1	401	Q96E52
AELGTACLKARVALL	TCN2	261	P20062
LLASDKCGEAIRSLQ	BROX	261	Q5VW32
AAALIACKTLRSLNL	NLRP9	906	Q7RTR0
LGAGRQSLLRTNKSC	PHIP	101	Q8WWQ0
NASGTFAIRLLKILC	SERPINB9	6	P50453
LLLCFGSQRAKAATA	PRSS27	11	Q9BQR3
SQCAKNLGTALAELR	TLN1	1021	Q9Y490
TGKTLLARACAAQTK	PSMC3	231	P17980
CRKSLALLGQTFSLA	SUGP2	476	Q8IX01
AARLVAAKCTLAARV	PRPF31	291	Q8WWY3
GLSRNLKFLTDACAL	TLNRD1	186	Q9H1K6
CQFLTRIAAGKTLDA	TERF1	126	P54274
LSSTLARCAKDILGF	PKD2L1	466	Q9P0L9
VACSGAAQVRIKILA	SYMPK	576	Q92797
NKIRAASAVGICSEL	MTHFD2L	101	Q9H903
TCQKNAASALLVGRK	WDR59	676	Q6PJI9
LLALLCASASGNAIQ	ZG16	6	O60844
ACTLAISAKGIADRL	UEVLD	196	Q8IX04
FLLAATCLRGLKSVQ	SLC35E4	191	Q6ICL7
ALCSRALSNEILGLK	WNT10B	21	O00744
VLAIGSSRCKANTLG	UBR4	1201	Q5T4S7
QLLSCALCGSKVLAA	UBR4	3321	Q5T4S7
ALCGSKVLAALAASS	UBR4	3326	Q5T4S7
LLLACALSAAAVGLK	TMEM271	16	A0A286YF58
TASACALNLTRQGLA	ZYG11A	401	Q6WRX3
LLAAALKSHSGNISC	TBL2	81	Q9Y4P3
TRKALCLAASGVGAL	nan	151	Q6ZTC4
GLNSVINSLASAICK	ULK4	691	Q96C45
CALDLASEVGKLLSA	WDR54	256	Q9H977
LSAKNEAGIVSCTAR	MYPN	1246	Q86TC9